C. Ghasarossian, Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2 Current concepts in the management of urinary tract infections in adults. The Medical clinics of, Ronald AR North America, vol.68, pp.335-349, 1984.

R. Echols, R. Tosiello, D. Haverstock, and A. Tice, Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis, Clinical Infectious Diseases, vol.29, issue.1, pp.113-119, 1999.
DOI : 10.1086/520138

J. Warren, E. Abrutyn, J. Hebel, J. Johnson, A. Schaeffer et al., Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women, Clinical Infectious Diseases, vol.29, issue.4, 1999.
DOI : 10.1086/520427

E. Denes, J. Prouzergue, S. Ducroix-roubertou, C. Aupetit, and P. Weinbreck, Antibiotic prescription by general practitioners for urinary tract infections in outpatients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of, Clinical Microbiology, vol.31, pp.3079-3083, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00741865

K. Gupta, T. Hooton, K. Naber, B. Wullt, R. Colgan et al., International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Clinical infectious diseases : an official publication of the Infectious Diseases Society, America, vol.52, pp.103-120, 2011.

T. Hooton, D. Scholes, J. Hughes, C. Winter, P. Roberts et al., A Prospective Study of Risk Factors for Symptomatic Urinary Tract Infection in Young Women, New England Journal of Medicine, vol.335, issue.7, pp.468-474, 1996.
DOI : 10.1056/NEJM199608153350703

D. Scholes, T. Hooton, P. Roberts, K. Gupta, A. Stapleton et al., Risk Factors Associated with Acute Pyelonephritis in Healthy Women, Annals of Internal Medicine, vol.142, issue.1, pp.20-27, 2005.
DOI : 10.7326/0003-4819-142-1-200501040-00008

S. Jackson, E. Boyko, D. Scholes, L. Abraham, K. Gupta et al., Predictors of urinary tract infection after menopause: A prospective study, The American Journal of Medicine, vol.117, issue.12, pp.903-911, 2004.
DOI : 10.1016/j.amjmed.2004.07.045

C. Czaja, D. Scholes, T. Hooton, and W. Stamm, Population-based epidemiologic analysis of acute pyelonephritis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.45, pp.273-280, 2007.

T. Hooton, Uncomplicated Urinary Tract Infection, New England Journal of Medicine, vol.366, issue.11, pp.1028-1037, 2012.
DOI : 10.1056/NEJMcp1104429

K. Gupta and B. Trautner, In the clinic. Urinary tract infection, Annals of internal medicine, vol.156, pp.3-4, 2012.

T. Hooton, P. Roberts, M. Cox, and A. Stapleton, Voided Midstream Urine Culture and Acute Cystitis in Premenopausal Women, New England Journal of Medicine, vol.369, issue.20, pp.1883-1891, 2013.
DOI : 10.1056/NEJMoa1302186

G. Kahlmeter, Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECOaSENS study, International Journal of Antimicrobial Agents, vol.22, issue.2, pp.49-52, 2003.
DOI : 10.1016/S0924-8579(03)00229-2

G. Kahlmeter, An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOmiddle dotSENS Project, Journal of Antimicrobial Chemotherapy, vol.51, issue.1, pp.69-76, 2003.
DOI : 10.1093/jac/dkg028

K. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei, Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy, European Urology, vol.54, issue.5, pp.1164-1175, 2008.
DOI : 10.1016/j.eururo.2008.05.010

G. Zhanel, T. Hisanaga, N. Laing, M. Decorby, K. Nichol et al., Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA), International Journal of Antimicrobial Agents, vol.27, issue.6, pp.468-475, 2006.
DOI : 10.1016/j.ijantimicag.2006.02.009

G. Sanchez, R. Master, J. Karlowsky, and J. Bordon, In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010, Antimicrobial Agents and Chemotherapy, vol.56, issue.4, pp.2181-2183, 2000.
DOI : 10.1128/AAC.06060-11

S. Swami, J. Liesinger, N. Shah, L. Baddour, and R. Banerjee, Incidence of Antibiotic-Resistant Escherichia coli Bacteriuria According to Age and Location of Onset: A Population-Based Study From Olmsted County, Minnesota, Mayo Clinic Proceedings, vol.87, issue.8, pp.753-759, 2012.
DOI : 10.1016/j.mayocp.2012.02.025

K. Gupta, T. Hooton, and L. Miller, Managing uncomplicated urinary tract infection--making sense out of resistance data. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.53, pp.1041-1042, 2011.

D. Paterson, Collateral damage" from cephalosporin or quinolone antibiotic therapy Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.38, issue.4, pp.341-345, 2004.

G. Schito, K. Naber, H. Botto, J. Palou, T. Mazzei et al., The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections, International Journal of Antimicrobial Agents, vol.34, issue.5, pp.407-413, 2009.
DOI : 10.1016/j.ijantimicag.2009.04.012

URL : https://hal.archives-ouvertes.fr/hal-00556347

P. Ho, K. Yip, K. Chow, J. Lo, T. Que et al., Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in, Diagnostic microbiology and infectious disease, pp.87-93, 2006.

S. Bent, B. Nallamothu, D. Simel, S. Fihn, and S. Saint, Does This Woman Have an Acute Uncomplicated Urinary Tract Infection?, JAMA, vol.287, issue.20, pp.2701-2710, 2002.
DOI : 10.1001/jama.287.20.2701

A. Jadad, R. Moore, D. Carroll, C. Jenkinson, D. Reynolds et al., Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

J. Higgins, S. Thompson, J. Deeks, and D. Altman, Measuring inconsistency in meta-analyses, BMJ, vol.327, issue.7414, pp.557-560, 2003.
DOI : 10.1136/bmj.327.7414.557

O. Bozkurt, C. Kara, and S. Akarsu, Comparison efficacy of single dose fosfomycin with ciprofloxacin in the treatment of urinary tract infection in symptomatic women, pp.360-362, 2008.

K. Gupta, T. Hooton, and W. Stamm, Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.243-246, 2005.
DOI : 10.1093/jac/dki169

G. Stein, Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection, Clinical Therapeutics, vol.21, issue.11, pp.1864-1872, 1999.
DOI : 10.1016/S0149-2918(00)86734-X

M. Minassian, D. Lewis, D. Chattopadhyay, B. Bovill, G. Duckworth et al., A comparison between single-dose fosfomycin trometamol (Monuril??) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women, International Journal of Antimicrobial Agents, vol.10, issue.1, pp.39-47, 1998.
DOI : 10.1016/S0924-8579(98)00021-1

C. Richaud, Le traitement monodose de la cystite non compliqu??e chez la femme ?? propos d'un essai fosfomycine trom??tamol (Monuril??) versus p??floxacine, M??decine et Maladies Infectieuses, vol.25, issue.2, pp.154-159, 1995.
DOI : 10.1016/S0399-077X(05)80760-7

G. Elhanan, H. Tabenkin, R. Yahalom, and R. Raz, Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women., Antimicrobial Agents and Chemotherapy, vol.38, issue.11, pp.2612-2614, 1994.
DOI : 10.1128/AAC.38.11.2612

E. Van-pienbroek, J. Hermans, A. Kaptein, and J. Mulder, Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharmacy world & science, PWS, vol.15, pp.257-262, 1993.

R. Cortes, T. Pascual, L. Arnal, S. Orozco, F. Sunyer et al., Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections] Atencion primaria, Comunitaria, vol.10, pp.1007-1012, 1992.

Z. De-jong, F. Pontonnier, and P. Plante, Single-Dose Fosfomycin Trometamol (Monuril) versus Multiple-Dose Norfloxacin: Results of a Multicenter Study in Females with Uncomplicated Lower Urinary Tract Infections, Urologia Internationalis, vol.46, issue.4, pp.344-348, 1991.
DOI : 10.1159/000282164

J. Boerema and F. Willems, Einzeldosis-Therapie mit Fosfomycin Trometamol verglichen mit siebent??giger Norfloxacin-Therapie bei unkomplizierten Harnwegsinfektionen in der Allgemeinpraxis, Infection, vol.307, issue.Suppl. 1, pp.80-88, 1990.
DOI : 10.1007/BF01643433

P. Crocchiolo, Single-Dose Fosfomycin Trometamol versus Multiple-Dose Cotrimoxazole in the Treatment of Lower Urinary Tract Infections in General Practice, Chemotherapy, vol.36, issue.1, pp.37-40, 1990.
DOI : 10.1159/000238815

H. Davis, R. , O. Dowd, T. Holmes, W. Smail et al., A Comparative Double-Blind Randomised Study of Single Dose Fosfomycin Trometamol with Trimethoprim in the Treatment of Urinary Tract Infections in General Practice, Chemotherapy, vol.36, issue.1, pp.34-36, 1990.
DOI : 10.1159/000238814

K. Naber and U. Thyroff-friesinger, Fosfomycin Trometamol vesus Ofloxacin/Cotrimoxazol: Einmaltherapie bei akuten unkomplizierten Harnwegsinfektionen bei Frauen, Infection, vol.106, issue.Suppl. 1, pp.70-76, 1990.
DOI : 10.1007/BF01643431

H. Neu, Fosfomycin Trometamol versus Amoxycillin ??? Single-Dose Multicenter Study of Urinary Tract Infections, Chemotherapy, vol.36, issue.1, pp.19-23, 1990.
DOI : 10.1159/000238810

J. Reynaert, D. Van-eyck, and J. Vandepitte, Einzeldosis Fosfomycin Trometamol im Vergleich zu Mehrfachdosen Norfloxacin f??r drei Tage zur Therapie der unkomplizierten Harnwegsinfektion in der Allgemeinpraxis, Infection, vol.13, issue.Suppl. 1, pp.77-79, 1990.
DOI : 10.1007/BF01643432

F. Selvaggi, P. Ditonno, A. Traficante, M. Battaglia, D. Lorenzo et al., Fosfomycin Trometamol (Monuril) versus Norfloxacin in Single Dose for Adult Female Uncomplicated UTIs, Chemotherapy, vol.36, issue.1, pp.31-33, 1990.
DOI : 10.1159/000238813

N. Ceran, D. Mert, F. Kocdogan, I. Erdem, R. Adalati et al., A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections, Journal of Infection and Chemotherapy, vol.16, issue.6, pp.424-430, 2010.
DOI : 10.1007/s10156-010-0079-z

H. Budiono, S. Hardjowijoto, T. Djojodimejo, D. Soebadi, and A. Widodo, Comparison of fosfomycin trometamol with ciprofloxacin for uncomplicated UTI due to E. coli in women, Ind J Urology, vol.22, pp.39-43, 2015.

V. Rafalskiy, L. Khodnevitch, I. Malev, and A. Derevickiy, Randomised clinical trial of short-course norfloxacin vs single dose fosfomycin for uncomplicated UTI in region with 10 resistance level of uropathogenic E. coli to fluoroquinolone(eds) Book Randomised clinical trial of short-course norfloxacin vs single dose fosfomycin for uncomplicated UTI in region, 2009.

A. Stapleton, P. Roberts, M. Cox, and T. Hooton, Pilot study of fosfomycin trometamol compared with trimethoprim-sulfamethoxazole for acute uncomplicated cystitis in(eds) Book Pilot study of fosfomycin trometamol compared with trimethoprim-sulfamethoxazole for acute uncomplicated cystitis in women, p.pp, 2011.

M. Falagas, E. Vouloumanou, A. Togias, M. Karadima, A. Kapaskelis et al., Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials, Journal of Antimicrobial Chemotherapy, vol.65, issue.9, pp.1862-1877, 2010.
DOI : 10.1093/jac/dkq237

Y. Neuzillet, K. Naber, G. Schito, L. Gualco, and H. Botto, French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy, M??decine et Maladies Infectieuses, vol.42, issue.2, pp.66-75, 2012.
DOI : 10.1016/j.medmal.2011.07.005

F. Kahan, J. Kahan, and P. Cassidy, THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN), Annals of the New York Academy of Sciences, vol.245, issue.1 Mode of Actio, pp.364-386, 1974.
DOI : 10.1016/0014-5793(71)80218-1

V. Ferrari, L. Bonanomi, and M. Borgia, A new fosfomycin derivative with much improved bioavailability by oral route, Chemiotherapia Antimicrobia, vol.4, pp.59-63, 1981.

A. Barry, M. Pfaller, P. Fuchs, F. Tenover, L. Reller et al., Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. European journal of clinical microbiology & infectious diseases : official publication of the European Society of, Clinical Microbiology, vol.12, pp.352-356, 1993.